Wolverine Trading
KIN

Wolverine Trading’s Kindred Biosciences, Inc. KIN Stock Holding History

Wolverine Trading’s Portfolio KIN Stock Details KIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-11,700
Closed -$53K – 7090
2021
Q1 		$53K Buy
+11,700
New +$56.5K ﹤0.01% 5633
2019
Q3 		– Sell
-10,700
Closed -$89K – 5274
2019
Q2 		$89K Buy
+10,700
New +$92.3K ﹤0.01% 4053

Other funds holding KIN

PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

Wolverine Trading's KIN Position: Q1 2021 in Review

Wolverine Trading sold out of Kindred Biosciences, Inc. (KIN) in Q1 2021, closing a stake of 21,568 shares — an estimated $104K sold.

Wolverine Trading first reported a position in KIN in Q1 2017 and held it in 7 quarters. The position peaked at $343K in Q2 2017. 84 funds tracked by Wall St. Rank hold KIN as of Q1 2021.

  • Wolverine Trading reported no remaining Kindred Biosciences, Inc. position as of Q1 2021 after selling out during the quarter.
  • Wolverine Trading sold 21,568 Kindred Biosciences, Inc. shares in Q1 2021, an estimated $104K.
  • Wolverine Trading first reported a position in Kindred Biosciences, Inc. in Q1 2017 and held it in 7 quarters.
  • Wolverine Trading's Kindred Biosciences, Inc. position peaked at $343K in Q2 2017.
  • 84 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q1 2021.

Based on Wolverine Trading's 13F filing for Q1 2021, filed 14 May 2021.